Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) EBT Margin (2016 - 2024)

vTv Therapeutics (VTVT) has disclosed EBT Margin for 10 consecutive years, with 26100.0% as the latest value for Q4 2024.

  • Quarterly EBT Margin changed N/A to 26100.0% in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 166935.29% through Sep 2025, down 16467439.0% year-over-year, with the annual reading at 2222.71% for FY2024, N/A changed from the prior year.
  • EBT Margin hit 26100.0% in Q4 2024 for vTv Therapeutics, down from 591.9% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 25.11% in Q4 2020 to a low of 105366.67% in Q4 2021.
  • Historically, EBT Margin has averaged 31446.3% across 4 years, with a median of 17722.22% in 2021.
  • Biggest five-year swings in EBT Margin: surged 9833940bps in 2020 and later plummeted -10539178bps in 2021.
  • Year by year, EBT Margin stood at 25.11% in 2020, then tumbled by -419665bps to 105366.67% in 2021, then skyrocketed by 36bps to 67666.67% in 2022, then soared by 61bps to 26100.0% in 2024.
  • Business Quant data shows EBT Margin for VTVT at 26100.0% in Q4 2024, 591.9% in Q1 2024, and 67666.67% in Q4 2022.